These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 25275736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK, Elewski BE, Sugarman JL, Ieda C, Kawabata H, Kang R, Pillai R, Olin JT, Watanabe S.
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR, Scher RK.
    Expert Rev Clin Pharmacol; 2015 Jul; 8(6):719-31. PubMed ID: 26325488
    [Abstract] [Full Text] [Related]

  • 5. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC, Joseph WS.
    J Drugs Dermatol; 2014 Oct; 13(10):1186-90. PubMed ID: 25607552
    [Abstract] [Full Text] [Related]

  • 6. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH, Bucko AD, Oizumi N, Kawabata H, Olin JT, Pillai R.
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [Abstract] [Full Text] [Related]

  • 7. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT.
    J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10.
    Rosen T.
    Cutis; 2015 Sep; 96(3):197-201. PubMed ID: 26562270
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M, Sugimoto N, Kawabata H, Yamakawa E, Kodera N, Pillai R, Tatsumi Y.
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [Abstract] [Full Text] [Related]

  • 14. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
    Eichenfield LF, Elewski B, Sugarman JL, Rosen T, Vlahovic TC, Gupta AK, Stein Gold L, Pillai R, Guenin E.
    J Drugs Dermatol; 2020 Sep 01; 19(9):867-872. PubMed ID: 33026753
    [Abstract] [Full Text] [Related]

  • 15. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P.
    J Drugs Dermatol; 2015 Jan 01; 14(1):58-62. PubMed ID: 25607909
    [Abstract] [Full Text] [Related]

  • 16. Topical treatment of onychomycosis with efinaconazole solution 10%.
    Rich P.
    Cutis; 2013 Jun 01; 91(6):305-7. PubMed ID: 23837154
    [Abstract] [Full Text] [Related]

  • 17. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE, Cantrell W, Lin T.
    J Drugs Dermatol; 2018 Feb 01; 17(2):175-178. PubMed ID: 29462225
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.